FDA Drug Application (202365) for SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE by WATSON LABS INC

Back to FDA Applications sponsored by WATSON LABS INC

Application Number202365
Product Number001
FormTABLET;ORAL
Dosage50MG;500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
Active IngredientSITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by WATSON LABS INC